Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 16 January 2019 |
| Author/s |
author: Denis Moro-Sibilot Florian Guisier |
| Publication date | January 16, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |